Table 1

Clinical details, biochemical data and mutation spectrum in the HMBS gene in South African patients with AIP

PatientSex/raceClinical information (as far as can be established)Urinary PBG (<1.6 µmol/mmolcreatine)Plasma fluorescence emission peak (619 nm)Urine total porphyrins (<26.2 nmol/mmolcreatine)Location of mutationMolecular defectPredicted protein product
1F/B*Tetraparesis31.2Present111.7Exon 5c.181delGp.Asp61Thrfs*37
2–3F/MAUnknown28.6Present46.3Exon 8c.346C>Tp.Arg116Trp
F/MAUnknown142.6Present888.6
4M/BProgressive muscular atrophy147.8Present259.2Exon 9c.445C>Tp.Arg149X
5M/BUnknown11.2PresentUnknownExon 10c.583C>Tp.Arg195Cys
6F/BUnknown31.1Present811.9Exon 12c.706G>Ap.Gly236Ser
7–9F/BUnknown58.6Present256.4Exon 12c.771_772insTp.Leu258Leufs*33
F/BUnknown103.5Present590.2
F/MA*Unknown33.7Present598.0
10–13M/C†Abdominal pain18.9Unknown71.1Exon 14c.848G>Ap.Trp283X
F/C†Acute attack65.8Unknown201.5
M/C‡Not performing well at school0.4NormalNot done
F/C‡AsymptomaticNot doneNot doneNot done
14–17F/MA*Abdominal pain, weakness262.2Present1537.4No mutations found in these patients  
F/BAcute attack30.5Unknown136.5
F/MAChronic alcohol abuse, abdominal pain, constipation, seizures, weakness65.6Unknown119.1
F/MAUnknown120.6Present154.5
18–19M/CSymptoms triggered by commencement of tuberculosis therapy37.8Present126.7Exon 7c.292A>Gp.Lys98Glu§
M/CUnknown12.6Present155.8
20M/MAAcute attack44.3Present376.5Exon 12c.689_690delACp.Asp230Aspfs*20§
21F/BAbdominal pain, polyneuropathy43.1Present102.6Intron 4c.161-1G>ASplicing aberration§
22F/BAcute attack33.2Present39.5Intron 8c.422+3_6delAAGTSplicing aberration§
  • *Patient deceased.

  • †Siblings.

  • ‡Siblings and offspring of M/C†.

  • §Novel mutations.

  • AIP, acute intermittent porphyria; B: Black; C: Caucasian; F: female; HMBS, hydroxymethylbilane synthase; M: male; MA: mixed ancestry; PBG, porphobilinogen.